None of the bipartisan marijuana or psychedelics amendments that bipartisan lawmakers proposed as part of a large-scale defense bill will advance to the floor following a key House committee action.
More than a dozen drug policy amendments were offered by members to potentially be attached to the National Defense Authorization Act (NDAA). But Republican leadership in the House Rules Committee declined to make any of them in order for floor votes, despite the testimony of certain sponsors who implored the panel to accept them.
The committee released a second rule and list of cleared amendments for NDAA early Thursday morning. It had advanced an initial package of generally non-controversial proposals on Tuesday following controversy over other unrelated amendments on issues like gender-affirming care and Ukraine support, and advocates hoped they’d return to the bill and approve at least some of the reform measures, but that didn’t materialize.
The proposed amendments touched on issues like eliminating cannabis drug testing for people trying to enlist in the military, protecting federal workers from losing security clearances for marijuana, letting Department of Veterans Affairs doctors issue medical cannabis recommendations, allowing servicemembers to use CBD or other hemp-derived products and investigating the therapeutic potential of
Read full article on Marijuana Moment
